ArticleCancer immunology, immunotherapy : CII2022

Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors.

Da Hyun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.